For a patient facing a new cancer diagnosis, the immediate focus is on survival. Yet, for many, the treatments that save lives can also end the possibility of having biological children. This is the moment Oncovana wants to enter, with a digital platform designed to connect oncology teams, fertility clinics, and patients to coordinate fertility preservation before treatment begins [Oncovana.com, 2024]. The company, founded in early 2024, is betting that a software layer can streamline a process that is often fragmented, emotionally fraught, and time-sensitive.
The Wedge in a $16 Billion Market
The fertility market is large, estimated at $16 billion, but general services often overlook the specific, urgent needs of oncology patients [American Bazaar Online, November 2024]. Oncovana is positioning itself as a wedge into that broader market by serving a distinct and underserved population: the roughly two million people diagnosed with cancer each year in the U.S. who may face treatment-induced infertility [American Bazaar Online, November 2024]. The platform aims to provide education, resources, and a streamlined pathway to services like egg or sperm freezing, acting as a coordination hub that sits between the cancer center and the fertility clinic [GW Today, 2024].
A Team Forged in Public Health
The founding team is a distinctive feature, composed entirely of DrPH students from George Washington University's Milken Institute School of Public Health. Bhakthi Sahgal, John Russell, Bridget Kelly, Alvaro Rivera, and Ornsiree Junchaya bring academic backgrounds in oncology, public health, and product design to the venture [American Bazaar Online, November 2024]. This public health lens is central to their approach, framing the problem as a systemic coordination failure rather than just a software gap. The company gained early validation by winning a pitch competition at DC Startup and Tech Week and was later accepted into the Halcyon Accelerator, where it was showcased alongside other health innovators in a 2025 event with Kaiser Permanente [Technical.ly] [Kaiser Permanente, 2025].
The Path to Clinical Integration
Oncovana's ambitions hinge on integration into clinical workflows. The company is exploring partnerships with hospitals and cancer centers, a necessary step for the platform to reach patients at the point of diagnosis [Halcyon Accelerator]. However, the path from academic project to deployed clinical tool is steep. The company has not disclosed any funding rounds, named customers, or live deployments, placing it firmly in the exploratory phase. Its success will be measured by its ability to secure those first institutional partnerships and demonstrate that its coordination model reduces delays and improves patient access to fertility services.
The Standard of Care Today
For a young adult diagnosed with cancer today, navigating fertility preservation is often a solitary and confusing scramble. The responsibility typically falls on the patient or a family member to research options, find a clinic, schedule consultations, and coordinate between their oncologist and a reproductive endocrinologist, all while processing a life-altering diagnosis. Time is the critical constraint, as chemotherapy or radiation often cannot be delayed. This standard of care, reliant on patient advocacy and luck, results in significant disparities in who accesses preservation services. Oncovana's bet is that by making the pathway visible and navigable, it can turn an exception into a standard part of oncology care.
Sources
- [Oncovana.com, 2024] Company website and platform description | https://www.oncovana.com
- [American Bazaar Online, November 2024] Oncovana: A new frontier in fertility support for cancer patients | https://americanbazaaronline.com/2024/11/02/oncovana-in-fertility-support-for-cancer-patients-456870/
- [GW Today, 2024] What’s the Big Idea? Oncovana Guides Cancer Patients to Fertility Preservation Options | https://gwtoday.gwu.edu/whats-big-idea-oncovana-guides-cancer-patients-fertility-preservation-options
- [Technical.ly] Meet DC Startup and Tech Week’s pitch competition winners | https://technical.ly/startups/dc-startup-tech-week-2024-pitch-competition-winners/
- [Halcyon Accelerator] Oncovana venture profile | https://halcyonaccelerator.org/venture/oncovana/
- [Kaiser Permanente, 2025] Kaiser Permanente and Halcyon Showcase Health Care Innovation at 2025 Innovation Spotlight | https://kpproud-midatlantic.kaiserpermanente.org/kaiser-permanente-and-halcyon-showcase-health-care-innovation-at-2025-innovation-spotlight/